|
|
Office Locations:
|
676 North Michigan Avenue
Chicago, IL 60611
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Satter Investment Management, or SIM, is a private investment firm and family office with significant investments in several life sciences and medical technology companies. Muneer Satter is a retired partner of Goldman Sachs, where he was a partner of the firm for sixteen years. He spent his career in the Merchant Banking Division, which manages the firm's private investments. He has also managed the Satter Foundation, a private family foundation since 1997. He was chairman of Akebia Therapeutics from 2012-2018, during which time it grew from a private company with a $60 million valuation to a publicly-traded biotech company with a $1.5 billion dollar valuation.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
